For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.

Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

Cioppa led the clinical development of highly successful meningitis and influenza vaccines at GSK, said Vicebio, while Smal has been involved in the R&D and manufacturing of several vaccines as ...

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted ...

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

Credit: GSK Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. The product was discontinued for business reasons and not for any safety or effectiveness issues. GSK has ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The revenue for Depemokimab is expected to reach an annual total of $512 mn by 2037 in the US based off GlobalData’s Expiry Model ... measure that accounts for the risk of a drug in clinical ...